QALO — the company that put silicone rings on two million hands — just made its biggest move into health tech. The QALO SL-1 Smart Band launched September 29 at $199.95, a screenless wristband built for workouts and hard labor that shares one subscription-free health profile with the company’s SR-2 Smart Ring. It’s on sale now at qalo.com, with 50 Walmart locations coming this fall. BusinessWire carried the announcement.
The pitch is simple: wear the ring for daily life and sleep, switch to the band for CrossFit, construction shifts, or anything where a ring gets in the way — and your sleep, stress, recovery, and activity data stay on one continuous timeline instead of fragmenting across devices.
What It Tracks
The SL-1 is screenless, water-resistant, and rated for 12+ days of battery life. It tracks sleep, movement, SpO2, heart rate, stress, HRV, skin temperature, and women’s health metrics. The headline software features are a Daily Q Score (a 1–100 snapshot combining sleep, HRV, movement, and stress) and live heart rate tracking with elapsed time and step count during workouts.
It’s also FSA/HSA eligible — a deliberate signal that QALO wants this treated as health equipment, not a gadget. And notably, there is no subscription. Your data isn’t paywalled behind a monthly plan.
The Anti-Subscription Bet
This is where the SL-1 gets interesting as a business story rather than just a product story. The screenless health-tracker category — Oura, Whoop, and now a wave of 2026 entrants like the Fitbit Air — has largely converged on subscriptions as the revenue engine. Hardware gets you in the door; the monthly fee keeps the lights on.
QALO is going the other way: a $199.95 one-time purchase, no recurring fee, with the company betting that volume (its user base is up 400% year over year) and retail distribution through Walmart will do the work instead. For buyers burned by subscription creep across every category of their digital lives, that’s a genuine differentiator — not a spec, a pricing philosophy.
The Missing Features
One wrinkle worth flagging honestly: Gadgets & Wearables notes that the SL-1’s FCC filing described an ECG measurement with a 30-second reading and exportable waveform, plus references to blood pressure, blood glucose, and sleep-apnea monitoring — none of which appear in the launch announcement or product page. The filing may describe capabilities that aren’t enabled at launch, or features planned for later. Either way, buyers should purchase the band for what’s shipping today, not the paperwork.
Why This Matters
The SL-1 is a bet that the wearable market’s next fight isn’t about sensors — it’s about the business model. A screenless band with no subscription, sold at Walmart, FSA-eligible, aimed at firefighters, mechanics, and CrossFit athletes rather than tech early adopters: that’s a health device wearing work boots. If QALO can make the unit economics work without a monthly fee, every subscription wearable suddenly has a pricing problem.
Meanwhile in Gadgets:
